[KITASAMYCIN. EXPERIMENTAL "IN VITRO" STUDY AND 1ST CLINICAL RESULTS].
D000900:Anti-Bacterial Agents; D002751:Chlortetracycline; D003880:Dermatology; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004917:Erythromycin; D005762:Gastroenterology; D066298:In Vitro Techniques; D015939:Kitasamycin; D007938:Leukemia; D008712:Methicillin; D009675:Novobiocin; D010019:Osteomyelitis; D010036:Otolaryngology; D010406:Penicillins; D010600:Pharmacology; D012106:Research; D012141:Respiratory Tract Infections; D012294:Rifamycins; D013210:Staphylococcus; D013291:Streptococcus; D014552:Urinary Tract Infections
D000900:Anti-Bacterial Agents; D010406:Penicillins; D012294:Rifamycins; D015939:Kitasamycin; D009675:Novobiocin; D004917:Erythromycin; C023808:rifamycin SV; D008712:Methicillin; D002751:Chlortetracycline
ANTIBIOTICS; CHLORTETRACYCLINE; DERMATOLOGY; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; EXPERIMENTAL LAB STUDY; GASTROENTEROLOGY; LEUKEMIA; METHICILLIN; NOVOBIOCIN; OSTEOMYELITIS; OTORHINOLARYNGOLOGY; PENICILLIN; PHARMACOLOGY; RESPIRATORY TRACT INFECTIONS; RIFOMYCIN; STAPHYLOCOCCUS; STREPTOCOCCUS; URINARY TRACT INFECTIONS
LA KITASAMYCINE. ETUDE EXP'ERIMENTALE "IN VITRO" ET PREMIERS R'ESULTATS CLINIQUES.